Greenberg, B., Butler, J., Felker, G. M., Ponikowski, P., Voors, A. A., Jaski, B., … Zsebo, K. M. (2015). CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure. In Journal of Cardiac Failure (Vol. 21, pp. 939–940). Elsevier BV. https://doi.org/10.1016/j.cardfail.2015.09.012

Greenberg, Barry, Javed Butler, G Michael Felker, Piotr Ponikowski, Adriaan A. Voors, Brian Jaski, Alexander R. Lyon, Janice M. Pogoda, Jeffrey J. Rudy, and Krisztina M. Zsebo. “CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure.” In Journal of Cardiac Failure, 21:939–40. Elsevier BV, 2015. https://doi.org/10.1016/j.cardfail.2015.09.012.

Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Jaski B, et al. CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure. In: Journal of Cardiac Failure. Elsevier BV; 2015. p. 939–40.

Greenberg, Barry, et al. “CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure.” Journal of Cardiac Failure, vol. 21, no. 11, Elsevier BV, 2015, pp. 939–40. Crossref, doi:10.1016/j.cardfail.2015.09.012.

Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Jaski B, Lyon AR, Pogoda JM, Rudy JJ, Zsebo KM. CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure. Journal of Cardiac Failure. Elsevier BV; 2015. p. 939–940.